Bruker Corporation
NASDAQ:BRKRMedical - Devices
-$1.07 today
- Market cap
- $9.66B
- Beta
- 1.30
- P/E (TTM)
- -718.1
- EPS (TTM)
- -$0.08
- Dividend yield
- 0.37%
Volume 1.73M
Average 2.41M
BRKR Total Non-current Liabilities
All obligations due after more than one year.
Bruker CorporationNASDAQ: BRKR
Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total non-current liabilities falls 23.4% from a year ago
Total non-current liabilities stood at $2.39B at the end of Q2 FY2026, down 23.4% from a year earlier and up 5.3% from the prior quarter. Over 3 fiscal years it compounded at +16.1% a year.
Context
- Total non-current liabilities amounted to 39.5% of total assets at the end of Q2 FY2026, down 9.8 pp from a year earlier.
- Total non-current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total non-current liabilities keeps falling in the next quarterly balance sheet after a -23.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 2.45B USD
- Year-over-year change
- -9.5%
- 4-year CAGR
- +10.8%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.45B | -9.5% |
| FY2024 | 2024-12-31 | 2.71B | +65.8% |
| FY2023 | 2023-12-31 | 1.63B | +4.4% |
| FY2022 | 2022-12-31 | 1.57B | -3.7% |
| FY2021 | 2021-12-31 | 1.63B | — |
Total Non-current Liabilities vs competitors
How BRKR compares with its peers on the latest reported figures
- BRKR's Jun 2026 total non-current liabilities of $2.39B is the 7th highest of the 11 companies compared; the peer median is $3B.
- Its year-over-year change of -23.4% is the 10th highest of 11, against a peer median of +5.3%.
- Total non-current liabilities amounts to 39.5% of total assets for BRKR, versus a peer median of 31.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $45.3B | +22.5% | +5.0% | 39.7% | |
| Sep 2026 | $30.61B | +36.0% | -2.3% | 32.8% | |
| Jul 2026 | $7.16B | +364.1% | -13.8% | 28.9% | |
| Jul 2026 | $4.32B | +8.9% | +2.6% | 30.9% | |
| Jul 2026 | $3.54B | -14.4% | -11.7% | 29.4% | |
| Jun 2026 | $2.46B | -3.7% | +3.0% | 66.9% | |
| Jun 2026 | $2.39B | -23.4% | +16.1% | 39.5% | |
| Jun 2026 | $2.12B | -16.5% | -7.7% | 20.6% | |
| Jun 2026 | $1.95B | +63.9% | +2.8% | 33.1% | |
| Mar 2026 | $714.64M | +1.7% | -8.3% | 91.3% | |
| Sep 2026 | $109.86M | -73.6% | -9.2% | 4.2% | |
| Peer median (excluding BRKR) | $3B | +5.3% | -5.0% | 31.9% | |
Competitors are the stored peer set for BRKR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.07B | 645.5M | 488.3M | 183.4M | 298.8M |
| Short-term Investments | 100M | 0 | 0 | 0 | 0 |
| Net Receivables | 416.9M | 595.3M | 621.8M | 701.2M | 736M |
| Inventory | 710.1M | 800.1M | 968.3M | 1.07B | 1.09B |
| Other Current Assets | 176.6M | 29M | 30.3M | 39.6M | 47.9M |
| Total Current Assets | 2.47B | 2.11B | 2.16B | 2.05B | 2.21B |
| Property, Plant & Equipment (Net) | 466M | 538.2M | 691.4M | 814.8M | 910.6M |
| Goodwill | 339.5M | 457.6M | 582.6M | 1.51B | 1.55B |
| Intangible Assets | 211.8M | 270.9M | 330.5M | 912.5M | 899.6M |
| Long-term Investments | 0 | 0 | 0 | 0 | 8.2M |
| Tax Assets | 90.1M | 76.8M | 297.2M | 286.2M | 421.7M |
| Other Non-current Assets | 70.8M | 155.1M | 184M | 232.7M | 241.1M |
| Total Non-current Assets | 1.18B | 1.5B | 2.09B | 3.75B | 4.03B |
| Total Assets | 3.65B | 3.61B | 4.25B | 5.81B | 6.24B |
| Account Payables | 147.4M | 178.4M | 202.7M | 234.1M | 215.9M |
| Short-term Debt | 112.4M | 18.7M | 121.2M | 32.5M | 51.8M |
| Tax Payables | 90.5M | 104M | 157.4M | 142.5M | 0 |
| Deferred Revenue | 335.9M | 370.2M | 400M | 438.2M | 441.3M |
| Other Current Liabilities | 156.4M | 159.9M | 218.3M | 300.3M | 302.8M |
| Total Current Liabilities | 938.5M | 914.3M | 1.2B | 1.28B | 1.28B |
| Long-term Debt | 1.22B | 1.2B | 1.16B | 2.06B | 1.69B |
| Deferred Tax Liabilities | 46M | 62.3M | 67.7M | 118.5M | 112.5M |
| Deferred Revenue (Non-current) | 50.2M | 101.6M | 91.5M | 100M | 109.1M |
| Other Non-current Liabilities | 266.9M | 166.5M | 240.2M | 311M | 239.2M |
| Total Non-current Liabilities | 1.63B | 1.57B | 1.63B | 2.71B | 2.45B |
| Total Liabilities | 2.57B | 2.48B | 2.84B | 3.99B | 3.73B |
| Common Stock | 1.7M | 1.7M | 1.7M | 1.8M | 1.8M |
| Retained Earnings | 1.66B | 1.93B | 2.32B | 2.41B | 2.36B |
| Accumulated OCI | (8.2M) | 14.8M | 6M | (103.5M) | (79.5M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 14.3M | 18M | 36.1M | 34M | 53.8M |
| Total Equity | 1.08B | 1.13B | 1.41B | 1.82B | 2.51B |
| Total Debt | 1.39B | 1.27B | 1.38B | 2.25B | 2.04B |
| Net Debt | 325.7M | 624.9M | 891.3M | 2.06B | 1.74B |
Bruker Corporation
NASDAQ:BRKR
Intrinsic Alpha fair value
Locked
Current Price
$63.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.